Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Maass

Showing results (261-270 of 272) with videos related to

Pageof 28
Sort By:
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 25, 2017
Refining success of cardiac resynchronization therapy using a simple score predicting the amount of reverse ventricular remodelling: results from the Markers and Response to CRT (MARC) studyAlexander H Maass, Kevin Vernooy, Sofieke C Wijers, et al.
Heart (British Cardiac Society)|July 20, 2022
Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillationBao-Oanh Nguyen, Vanessa Weberndorfer, Harry Jgm Crijns, et al.
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|February 17, 2010
The medical engineering program of Forschungszentrum KarlsruheH Fischer, M Selig, J Vagner, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 10, 2020
Temporal patterns and short-term progression of paroxysmal atrial fibrillation: data from RACE VRuben R De With, Ömer Erküner, Michiel Rienstra, et al.
Journal of the American Heart Association|April 9, 2024
Impact of a Chronic Total Coronary Occlusion on the Incidence of Appropriate Implantable Cardioverter-Defibrillator Shocks and Mortality: A Substudy of the Dutch Outcome in ICD Therapy (DO-IT)) RegistryAnna van Veelen, Tom E Verstraelen, Yvemarie B O Somsen, et al.
American Heart Journal|May 22, 2012
Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapyLouise R A Olde Nordkamp, Reinoud E Knops, Gust H Bardy, et al.
The New England Journal of Medicine|May 14, 2010
An entirely subcutaneous implantable cardioverter-defibrillatorGust H Bardy, Warren M Smith, Margaret A Hood, et al.
International Journal of Cardiology|June 21, 2025
Sex-specific response to cardiac resynchronization therapy: the BIO|WOMEN trialJose Luis Zamorano, Gabor Vörös, Valeria Calvi, et al.
Heart Rhythm O2|July 28, 2025
Pain after subcutaneous implantable cardioverter-defibrillator implantation: A secondary analysis of the PRAETORIAN-DFT trialJolien A de Veld, Lonneke Smeding, Mikhael F El-Chami, et al.
Heart Rhythm|February 9, 2024
Predictive value of the PRAETORIAN score for defibrillation test success in patients with subcutaneous ICD: A subanalysis of the PRAETORIAN-DFT trialReinoud E Knops, Mikhael F El-Chami, Christelle Marquie, et al.
Pageof 28

Showing results (261-270 of 272) with videos related to

Sort By:
Pageof 28
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 25, 2017
Refining success of cardiac resynchronization therapy using a simple score predicting the amount of reverse ventricular remodelling: results from the Markers and Response to CRT (MARC) studyAlexander H Maass, Kevin Vernooy, Sofieke C Wijers, et al.
Heart (British Cardiac Society)|July 20, 2022
Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillationBao-Oanh Nguyen, Vanessa Weberndorfer, Harry Jgm Crijns, et al.
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|February 17, 2010
The medical engineering program of Forschungszentrum KarlsruheH Fischer, M Selig, J Vagner, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 10, 2020
Temporal patterns and short-term progression of paroxysmal atrial fibrillation: data from RACE VRuben R De With, Ömer Erküner, Michiel Rienstra, et al.
Journal of the American Heart Association|April 9, 2024
Impact of a Chronic Total Coronary Occlusion on the Incidence of Appropriate Implantable Cardioverter-Defibrillator Shocks and Mortality: A Substudy of the Dutch Outcome in ICD Therapy (DO-IT)) RegistryAnna van Veelen, Tom E Verstraelen, Yvemarie B O Somsen, et al.
American Heart Journal|May 22, 2012
Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapyLouise R A Olde Nordkamp, Reinoud E Knops, Gust H Bardy, et al.
The New England Journal of Medicine|May 14, 2010
An entirely subcutaneous implantable cardioverter-defibrillatorGust H Bardy, Warren M Smith, Margaret A Hood, et al.
International Journal of Cardiology|June 21, 2025
Sex-specific response to cardiac resynchronization therapy: the BIO|WOMEN trialJose Luis Zamorano, Gabor Vörös, Valeria Calvi, et al.
Heart Rhythm O2|July 28, 2025
Pain after subcutaneous implantable cardioverter-defibrillator implantation: A secondary analysis of the PRAETORIAN-DFT trialJolien A de Veld, Lonneke Smeding, Mikhael F El-Chami, et al.
Heart Rhythm|February 9, 2024
Predictive value of the PRAETORIAN score for defibrillation test success in patients with subcutaneous ICD: A subanalysis of the PRAETORIAN-DFT trialReinoud E Knops, Mikhael F El-Chami, Christelle Marquie, et al.
Pageof 28